NASDAQ:BCPC - Nasdaq - US0576652004 - Common Stock - Currency: USD
156.55
+0.54 (+0.35%)
The current stock price of BCPC is 156.55 USD. In the past month the price decreased by -6.39%. In the past year, price increased by 4.09%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
SHW | SHERWIN-WILLIAMS CO/THE | 30.93 | 88.76B | ||
ECL | ECOLAB INC | 36.87 | 71.31B | ||
DD | DUPONT DE NEMOURS INC | 16.21 | 27.62B | ||
PPG | PPG INDUSTRIES INC | 13.68 | 24.71B | ||
IFF | INTL FLAVORS & FRAGRANCES | 18.25 | 20.07B | ||
RPM | RPM INTERNATIONAL INC | 20.77 | 13.71B | ||
SQM | QUIMICA Y MINERA CHIL-SP ADR | N/A | 9.77B | ||
EMN | EASTMAN CHEMICAL CO | 9.4 | 8.89B | ||
AXTA | AXALTA COATING SYSTEMS LTD | 14.51 | 7.09B | ||
ALB | ALBEMARLE CORP | N/A | 6.89B | ||
NEU | NEWMARKET CORP | 12.25 | 5.84B | ||
CE | CELANESE CORP | 5.33 | 4.97B |
Balchem Corp. provides marketing of specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey and currently employs 1,361 full-time employees. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
BALCHEM CORP
5 Paragon Drive
Montvale NEW JERSEY 10958 US
CEO: Theodore L. Harris
Employees: 1290
Company Website: https://balchem.com/
Investor Relations: https://balchem.com/our-company/investor-relations
Phone: 18453265600
The current stock price of BCPC is 156.55 USD. The price increased by 0.35% in the last trading session.
The exchange symbol of BALCHEM CORP is BCPC and it is listed on the Nasdaq exchange.
BCPC stock is listed on the Nasdaq exchange.
8 analysts have analysed BCPC and the average price target is 203.32 USD. This implies a price increase of 29.88% is expected in the next year compared to the current price of 156.55. Check the BALCHEM CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BALCHEM CORP (BCPC) has a market capitalization of 5.09B USD. This makes BCPC a Mid Cap stock.
BALCHEM CORP (BCPC) currently has 1290 employees.
BALCHEM CORP (BCPC) has a support level at 154.22 and a resistance level at 157.2. Check the full technical report for a detailed analysis of BCPC support and resistance levels.
The Revenue of BALCHEM CORP (BCPC) is expected to grow by 6.51% in the next year. Check the estimates tab for more information on the BCPC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BALCHEM CORP (BCPC) has a dividend yield of 0.56%. The yearly dividend amount is currently 0.79. Check the full fundamental report for a detailed analysis of BCPC dividend history, reliability and sustainability.
BALCHEM CORP (BCPC) will report earnings on 2025-07-24, before the market open.
The PE ratio for BALCHEM CORP (BCPC) is 34.26. This is based on the reported non-GAAP earnings per share of 4.57 and the current share price of 156.55 USD. Check the full fundamental report for a full analysis of the valuation metrics for BCPC.
The outstanding short interest for BALCHEM CORP (BCPC) is 1.61% of its float. Check the ownership tab for more information on the BCPC short interest.
ChartMill assigns a technical rating of 1 / 10 to BCPC. When comparing the yearly performance of all stocks, BCPC turns out to be only a medium performer in the overall market: it outperformed 65.77% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to BCPC. BCPC scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months BCPC reported a non-GAAP Earnings per Share(EPS) of 4.57. The EPS increased by 12.01% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 14.16% | ||
ROA | 8.44% | ||
ROE | 11.3% | ||
Debt/Equity | 0.16 |
ChartMill assigns a Buy % Consensus number of 83% to BCPC. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 17.6% and a revenue growth 6.51% for BCPC